The OCEANIC-AF trial has raised concerns about factor XI inhibitors. Should physicians still bet on this class of ...

The Hong Kong company saw a reduction in body weight across both cohorts with no serious adverse events reported.

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

A photothermal, nanoparticle-based deep brain stimulation system restored motor skills in mice with Parkinson’s-like disease ...

For years, conventional wisdom has been that weight loss is a matter of willpower. Those who are overweight or obese just need to try harder to eat less and exercise more. But while diet and ...

This valuable study reports on the critical role of ANKRD5 (ANKEF1) in sperm motility and male fertility. However, the supporting data remain incomplete. This work will be of interest to biomedical ...

Apimeds Pharmaceuticals US (APUS) is planning to raise $20 million in an initial public offering on the week of February 24th, IPO Scoop reports. The company will be issuing 4,500,000 shares at ...

Apimeds Pharmaceuticals US, Inc. (APUS) expects to raise $20 million in an initial public offering (IPO) on Friday, February 21st, IPO Scoop reports. The company will issue 4,500,000 shares at ...

The new weight loss drug offers promising results for those who are overweight or obese. Learn about how Zepbound works, its ...